Associated Papers
Abstracts of the 14th C1-inhibitor Deficiency and Angioedema Workshop.
Unknown Author
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology, 2026
Insights From the First 820 Patients From the Brazilian Multicenter Registry of Hereditary Angioedema: The Key Role of Genetic Testing and Targeted Therapies.
Ferriani MPL et al.
The Journal of Allergy and Clinical Immunology. in Practice, 2025
Severe high-molecular-weight kininogen deficiency: clinical characteristics, deficiency-causing KNG1 variants, and estimated prevalence.
Adenaeuer A et al.
Journal of Thrombosis and Haemostasis : Jth, 2023
Mechanisms involved in hereditary angioedema with normal C1-inhibitor activity.
Shamanaev A et al.
Frontiers in Physiology, 2023
Pathophysiology and underlying mechanisms in hereditary angioedema.
López Lera A
Balkan Medical Journal, 2021
Deciphering the Genetics of Primary Angioedema with Normal Levels of C1 Inhibitor.
Loules G et al.
Journal of Clinical Medicine, 2020
Clinical features of genetically characterized types of hereditary angioedema with normal C1 inhibitor: a systematic review of qualitative evidence.
Bork K et al.
Orphanet Journal of Rare Diseases, 2020
Angioedema without urticaria: novel findings which must be measured in clinical setting.
Veronez CL et al.
Current Opinion in Allergy and Clinical Immunology, 2020
Hereditary angioedema cosegregating with a novel kininogen 1 gene mutation changing the N-terminal cleavage site of bradykinin.
Bork K et al.
Allergy, 2019
Bradykinin-Mediated Angioedema: An Update of the Genetic Causes and the Impact of Genomics.
Marcelino-Rodriguez I et al.
Frontiers in Genetics, 2019
Select a paper to view details